Skip to main content

Peer Review reports

From: A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

Original Submission
10 Aug 2021 Submitted Original manuscript
17 Oct 2021 Reviewed Reviewer Report - Alexander Gough
12 Jan 2022 Reviewed Reviewer Report - Patrick Harris
10 Feb 2022 Author responded Author comments - Aurema Otero González
Resubmission - Version 2
10 Feb 2022 Submitted Manuscript version 2
26 Mar 2022 Editorially accepted
12 Apr 2022 Article published 10.1186/s13063-022-06219-7

You can find further information about peer review here.

Back to article page